Dewpoint scientific founder Tony Hyman elected to the Leopoldina National Academy of Sciences
Dewpoint congratulates our scientific founder, Tony Hyman, for his election to the German Academy of Sciences Leopoldina. This prestigious award […]
Dewpoint congratulates our scientific founder, Tony Hyman, for his election to the German Academy of Sciences Leopoldina. This prestigious award […]
A Nature review of condensate focused start-ups has described Dewpoint as the “field’s frontrunner’. The article has profiled three condensate […]
The announcement of Dewpoint Therapeutics successful $77 million Series B raise has received significant attention in from both Industry and […]
Dewpoint congratulates its co-founder, Tony Hyman, who was this week elected to the National Academy of Sciences in honor of his […]
Dewpoint congratulates its co-founder Tony Hyman, for receiving the NOMIS Foundation’s Distinguished Scientist and Scholar Award. The award recognises outstanding contributions […]
Dewpoint Therapeutics co-founder Anthony Hyman will share the 2020 Wiley Prize in Biomedical Sciences for his foundational work on biomolecular […]
The announcement of Dewpoint Therapeutics $100M partnership Bayer to research new treatments for cardiovascular and gynecological diseases has received significant […]
Dewpoint congratulates our scientific founder, Richard Young, on being named to the National Academy of Medicine.
BERLIN / BOSTON, September 23, 2019 – Rounding out a year of tremendous growth on two continents, Dewpoint Therapeutics, the biomolecular condensates company, has […]
The announcement of the launch of Dewpoint Therapeutics, with $60 Million Series A funding has received significant attention from media […]
Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science